Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical needs. The company's primary areas of focus include HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.
Gilead Sciences was founded in June 1987 by Michael L. Riordan and is headquartered in Foster City, California, United States.
Gilead Sciences is known for its antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including notable drugs like Truvada, Harvoni, and Sovaldi. The company has also been involved in the development and distribution of Remdesivir, a treatment for COVID-19.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Daniel P. O'Day | Chairman & CEO | 7.27M | N/A | 1964 |
| Mr. Andrew D. Dickinson | Executive VP & CFO | 2.94M | N/A | 1970 |
| Ms. Deborah H. Telman | Executive VP of Corporate Affairs, General Counsel & Corporate Secretary | 2.32M | N/A | 1965 |
| Ms. Johanna Mercier | Chief Commercial Officer | 3.32M | N/A | 1970 |
| Dr. Merdad V. Parsey M.D., Ph.D. | Chief Medical Officer | 3.07M | N/A | 1963 |
| Ms. Sandra Patterson | Senior VP, Corporate Controller & Principal Accounting Officer | N/A | N/A | 1967 |
| Ms. Jacquie Ross C.F.A. | Vice President of Investor Relations | N/A | N/A | N/A |
| Ms. Jyoti K. Mehra | Executive Vice President of Human Resources | N/A | N/A | 1976 |
| Dr. Linda Slanec Higgins Ph.D. | Senior Vice President of Research, Innovation & Portfolio | N/A | N/A | 1962 |
| Dr. Rudolf Ertl | Senior Vice President of Commercial Operations of Australia, Canada, Europe | N/A | N/A | 1946 |
Charts and financial information provided by TradingView, a popular charting & trading platform.
Check out even more advanced features or grab charts for your website.
This post has been viewed 5 times.
